BoldJet redefines injection and vaccination technology through needle-free, high-precision liquid microjet delivery directly into the skin. Utilizing advanced laser and microfluidics, BoldJet targets superficial skin layers with unparalleled accuracy, optimizing applications in both cosmetic procedures and medical injections, including vaccines and insulin. The microjet technology ensures virtually painless, minimally invasive injections, enhancing both safety and reliability. BoldJet's streamlined application process reduces operational costs and minimizes waste, requiring only basic medical training. Supported by grants from the European Innovation Council and leading Dutch institutions, BoldJet represents a significant technological advancement in the global cosmetics and healthcare market.